1. Beger HG, Büchler MW, Friess H. Chirurgische Ergebuisse und Indikation zu adjuvanten Mabnahmen beim Pankreascarcinom.Chirurg 1994; 65: 246–252.
2. Bruckner HW, Kalnicki S, Dalton J, Schwartz GK, Chesser MR, Mandeli J, Janus C. Combined modality therapy increasing local control of pancreatic cancer.Cancer Invest 1993; 11: 241–246.
3. Bruckner HW, Kalnicki S, Dalton J, Snady H, Schwartz GK, Chesser MR, Lehrer D, Mandeli J, Harpaz N, Janus C. Survival after combined modality therapy for pancreatic cancer.J Clin Gastroenterol 1993; 16: 199–203.
4. Bruckner HW, Snady H, Cooperman A, Chesser MR, Gattani M, Dalton J, Lavangini P, Schindelheim GS, Kelliher SK, Mandeli J. Combined modality therapy for effective local control in stage II and III unresectable pancreatic carcinoma.Proc ASCO 1995; 14: 216(abstract).
5. Aigner KR, Gailhofer S. Regional Chemotherapy for nonresectable, locally metastasized pancreatic cancer—four studies including 164 cases.Reg Cancer Treat Suppl 1993; 1:2(abstract).